NCT00175851View on ClinicalTrials.gov

Open Label Trial to Study the Long-term Safety and Efficacy of Seletracetam for the Treatment of Epilepsy

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 2008

Conditions
Epilepsy
Interventions
DRUG

Seletracetam (ucb 44212)

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY